24 May 2013
Keywords: lonza, bio, invest, cell, culture, plant, swiss
Article | 20 February 2006
l Swiss specialty chemicals firm Lonza and Singapore's Bio*One Capital are jointly building a large-scale mammalian cell culture plant ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.